- Recent Funding
- Investors
- +ND Capital
+ND Capital portfolio
+ND Capital has 6 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
It is a venture capital firm based in US, founded in 2002. It led 1 of the 8 rounds it joined. Its most recent investment on record is SiMa AI's $150M Series B+ round in September 2026, alongside AllianceBernstein, Maverick Capital, Alter Venture Partners and 8 others. By category, its portfolio leans toward Health and bio (5) and Robotics and hardware (2). It has co-invested with Dell Technologies Capital, Amplify Partners and Alter Venture Partners, most often Dell Technologies Capital (4 rounds).
About +ND Capital
What +ND Capital invests in
- Health and bio · 5 · 83%
- Robotics and hardware · 2 · 33%
- Manufacturing and industrial · 2 · 33%
- AI infrastructure and compute · 1 · 17%
+ND Capital recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $150M | AllianceBernstein, Maverick Capital, Alter Venture Partners +8 | ||
| Series A · $58M | OMX Ventures, Ahren Innovation Capital (lead), Fine Structure Ventures +2 | ||
| Seed | Korea Investment Partners, Pureos Bioventures | ||
| Series B+ · $49.06M · lead | Tippet Venture Partners (lead), RTX Ventures (lead) | ||
| Series B+ · $37M | Alter Venture Partners, Dell Technologies Capital, Lip-Bu Tan +4 | ||
| Series B+ · $80M | Alter Venture Partners, Dell Technologies Capital, Adage Capital Management +3 | ||
| Series B+ · $192M | DCVC Bio, Dream Variation Ventures, Blue Chip Venture Company +6 | ||
| Series A · $30M | Dell Technologies Capital (lead), Wing VC, Amplify Partners |
How +ND Capital invests
+ND Capital portfolio companies
SSiMa AI$150MSeries B+ · Sep 2026
CConstructive Bio$58MSeries A · Sep 2024
PPulseSight TherapeuticsSeed · Feb 2024
HH55$49.06MSeries B+ · Sep 2023
OOrca Bio$192MSeries B+ · Jun 2020
LLightcastbacker
| Company | Round with +ND Capital | Total raised | Latest raise |
|---|---|---|---|
AI infrastructure and compute |
Series B+ · $150M | $495M | Sep 28, 2026 Series B+ |
Health and bio |
Series A · $58M | $73M | Sep 24, 2024 Series A |
Health and bio |
Seed | undisclosed | Feb 14, 2025 Series A |
Robotics and hardware |
Series B+ · $49.06M · lead | $121.99M | Jul 24, 2024 Series B+ |
Health and bio |
Series B+ · $192M | $442M | Apr 29, 2026 Series B+ |
Health and bio |
backer | $27M | Apr 14, 2026 round |
Most frequent co-investors
DDell Technologies Capital4 shared rounds · last Sep 28, 2026
AAmplify Partners4 shared rounds · last Sep 28, 2026
AAlter Venture Partners3 shared rounds · last Sep 28, 2026
WWing VC3 shared rounds · last Oct 26, 2022
FFidelity2 shared rounds · last Oct 26, 2022
AAllianceBernstein1 shared round · last Sep 28, 2026
MMaverick Capital1 shared round · last Sep 28, 2026SStepStone Group1 shared round · last Sep 28, 2026
- FFidelity Management & Research Company1 shared round · last Sep 28, 2026
BBaron Capital1 shared round · last Sep 28, 2026
PPoint721 shared round · last Sep 28, 2026
JJ.P. Morgan1 shared round · last Sep 28, 2026
Similar investors
AAdage Capital Management6 companies · 4 deals in 12 mo
HHealthier Capital6 companies · 4 deals in 12 mo
SSymBiosis6 companies · 4 deals in 12 mo
UUC Investments6 companies · 4 deals in 12 moAAbingworth6 companies · 3 deals in 12 mo
HHBM Healthcare Investments6 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 8 rounds on Recent Funding that name +ND Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists +ND Capital, which is a subset of its real portfolio. API: /api/v1/investors/nd-capital (get a free API key). More: the most active VC firms and new venture capital funds.